Oxidative Stress in Parkinson's Disease: Potential Benefits of Antioxidant Supplementation.
Sandro PercárioAline S B Dos SantosEverton Luiz Pompeu VarelaAntônio Rafael Quadros GomesMichelli Erica Souza FerreiraThayana de Nazaré Araújo MoreiraMaria Fani DolabelaPublished in: Oxidative medicine and cellular longevity (2020)
Parkinson's disease (PD) occurs in approximately 1% of the population over 65 years of age and has become increasingly more common with advances in age. The number of individuals older than 60 years has been increasing in modern societies, as well as life expectancy in developing countries; therefore, PD may pose an impact on the economic, social, and health structures of these countries. Oxidative stress is highlighted as an important factor in the genesis of PD, involving several enzymes and signaling molecules in the underlying mechanisms of the disease. This review presents updated data on the involvement of oxidative stress in the disease, as well as the use of antioxidant supplements in its therapy.